Diabetes and cancer

Cited by (1,000)

Items 801–900 of 1,000

  1. Nomogram for Predicting Risk of Digestive Carcinoma Among Patients with Type 2 Diabetes
    Lu-Huai Feng, Kunpeng Bu, Shuang Ren, Zhenhua Yang, Li Bixun, Cheng-En Deng · 2020 · Diabetes Metabolic Syndrome and Obesity
  2. Mechanisms Linking Obesity to Cancer Risk
    Ikuyo Imayama, Caitlin E. Mason, Catherine R. Duggan · 2010 · Springer eBooks
  3. Endocrine and metabolic complications of advanced cancer
    Mark Bower, Louise A. Robinson, Sarah Cox · 2015
  4. THE EFFECT OF PIOGLITAZONE ON GENOMIC INSTABILITY IN INDUCED DIABETIC RATS
    Karam A. Amein, Moustafa Mahmoud Hamdy, RANIA ABD EL-EMAM, Fikry H. Osman · 2016 · Research Journal of Applied Biotechnology
  5. Sulfonylureas Glimepiride and Gliclazide Prevent Pancreatic Cancer Progression by Modulating Capn2 and Strengthening Tumor Immunotherapy
    Zilong Chen, Yuhuai Wang, Defu Zhao, Yunan Lin, Ling T. He · 2025 · Bratislavské lekárske listy/Bratislava medical journal
  6. Additive Anticancer and Antioxidant Effects of Metformin and Luteolin in Breast and Colorectal Cancer Cell Lines
    Katarzyna Gębczak, Łucja Cwynar-Zając, Monika Sapeta-Nowińska, Ewa Barg · 2025 · Pharmaceuticals
  7. Adiposity and Diabetes in Breast and Prostate Cancer
    Linda C Vona-Davis, David P. Rose · 2013 · Springer eBooks
  8. The Complementary Role of Exercise and Fasting in the Treatment of Cancer: A Narrative Review of Mechanisms Related to Metabolic Stress Elements
    Masomeh Hannani, Mahboubeh Zohari, Saleh Rahmati-Ahmadabad, Hoseyn Fatolahi, Hamideh Mokhtari, Sima Fazeli, Hoseyn Dalvand, Jalal Yarahmadi · 2022 · Disease and Diagnosis
  9. Case report: Type 2 diabetes mellitus with plantar malignant melanoma: Report of two cases
    Bi-ling Huang, Min Tan, Mingliu Li, Yuan-Yuan Teng, Min Zhou, Min Wang · 2023 · Frontiers in Oncology
  10. Effect of chronic viral hepatitis and metabolic factors on renal cancer risk in a large cohort in Republic of Korea
    Hoyoung Wang, Su Youn Nam, Junwoo Jo · 2023 · Preventive Medicine
  11. More new cancers in type 2 diabetes with diabetic foot disease: A longitudinal observational study
    Fadi Alkhami, Gauthier Borderie, Ninon Foussard, Alice Larroumet, Laurence Blanco, Marie‐Amélie Barbet‐Massin, Amandine Ferrière, Claire Ducos, Frédéric Domenge, Kamel Mohammedi et al. · 2023 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  12. The intersection of heart failure and cancer in women: a review
    Sara Moiz Tyebally, Ching‐Hui Sia, Daniel H. Chen, Aderonke Abiodun, Mayank Dalakoti, Po Fun Chan, Chieh Yang Koo, Li Ling Tan · 2024 · Frontiers in Cardiovascular Medicine
  13. Use of physiologically based kinetic modeling to predict neurotoxicity and genotoxicity of methylglyoxal in humans
    Liang Zheng, Xiyu Li, Frances Widjaja, Chen Liu, Ivonne M.C.M. Rietjens · 2024 · npj Science of Food
  14. The risk of cancer among insulin glargine users in Lithuania: A retrospective population-based study
    Justinas Jonušas, Mingailė Drevinskaitė, Donata Linkevičiūtė-Ulinskienė, Adomas Ladukas, Aušvydas Patašius, Lina Zabulienė, Giedrė Smailytė · 2024 · Open Medicine
  15. Diabetic ulcer with cutaneous squamous cell carcinoma: A case report
    Yun Peng Luo, Chenying Li, Yuqing Wang, Sheng-Min Xiang, Cheng Zhao · 2024 · World Journal of Clinical Oncology
  16. Insights on metabolic connections and interplay between cancer and diabetes: role of multi-target drugs
    Angeline Julius, Suresh Malakondaiah, Raghu Babu Pothireddy · 2025 · Discover Medicine
  17. Therapeutic Potential of Anti‐Diabetes Drugs and Anti‐Dyslipidemia Drugs to Mitigate Head and Neck Cancer Risk in Metabolic Syndrome
    Sujung Yeom, Dong Hoon Lee, Juhyun Song · 2025 · CNS Neuroscience & Therapeutics
  18. Influence of metformin therapy on breast cancer incidence and prognosis
    Ðordje Popovic, LAZAR S. POPOVIC, Edita Stokić, Dragana Tomić-Naglić, Milena Mitrović, Branka Kovačev-Zavišić · 2012 · Archive of oncology
  19. Le risque de cancer associé aux médicaments du diabète de type 2 (metformine, sulfonylurées et insulines)
    Jean‐Luc Faillie, J. Bringer · 2014 · Médecine des Maladies Métaboliques
  20. Adipositas, metabolisches Syndrom und Krebsentstehung
    Jocelyn de Heer · 2012 · Der Diabetologe
  21. Update on Pharmacotherapy for Type 2 Diabetes
    Sheikh Salahuddin Ahmed, Md Zulfikar Ali, Tarafdar Runa Laila, Hosne Ara Begum, Tarafdar Md Mujtaba Ali · 2013 · KYAMC Journal
  22. Emerging Link between Diabetes and Cancer
    Hiroshi Noto, Atsushi Goto, Tetsuro Tsujimoto, Mitsuhiko Noda · 2015 · Journal of General and Family Medicine
  23. Confirming an integrated pathology of diabetes and its complications by molecular biomarker-target network analysis
    Zide Zhao, Yingying Zhang, Fengchun Gai, Ying Wang · 2016 · Molecular Medicine Reports
  24. Diabetes, a Potential Threat to the Development and Progression of Tumor Cells in Individuals
    Sayantan Maitra, Stabak Das, Pradipta Banerjee · 2018 · Elsevier eBooks
  25. Vanadium Compounds as Enzyme Inhibitors with a Focus on Anticancer Effects
    Debbie C. Crans, Noah E. Barkley, Liliana Montezinho, M. Margarida C. A. Castro · 2019 · Royal Society of Chemistry eBooks
  26. Forging of nicotine for the effective management of diabetic wounds: A hybrid of scaffold hopping and molecular dynamics simulation approaches
    Bharat Kumar Reddy Sanapalli, Vidyasrilekha Yele, Dilep Kumar Sigalapalli, Nikhil Gadewal, AFZAL BASHA SHAIK, Richie Rashmin Bhandare, Sivakumar Annadurai, Veera Venkata Satyanarayana Reddy Karri · 2021 · Arabian Journal of Chemistry
  27. New Association Between Diabetes Mellitus and Pancreatic Cancer
    Salar Bakhtiyari, Monireh Rezaei, Zinat Shams, Bahareh Sadat Rasouli, Katayoun Dadeh Amirfard, Mohadeseh Soleymani Sadrabadi, Ali Gheysarzadeh, Karimeh Haghani · 2022 · Current Diabetes Reviews
  28. Role of LncRNA H19 in the Regulation of IGF-1R Expression: A Possible Association between Type 2 Diabetes and Hepatocellular Carcinoma: A Review Article
    M.Sc. NORA M. HUSSEIN NOURA SHEHABELDIN, M.D. MOHAMMED A.A. ZAHRAN HEBA K. MOHAMED · 2022 · The Medical Journal of Cairo University/The Medical Journal of Cairo University
  29. Synergistic Herb Interactions with Antidiabetic Drugs
    Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble · 2022 · Springer eBooks
  30. BIOLOGICAL ACTIVITIES OF EXTRACTS AND SECONDARY METABOLITE OF Macaranga mappa BARK AS AN ANTIDIABETIC BY α-GLUCOSIDASE INHIBITOR, ANTIOXIDANT, AND CYTOTOXICITY
    Antonius Herry Cahyana, Agus Rimus Liandi, Syukur Sakban Wicaksono, Akhmad Darmawan · 2023 · RASAYAN Journal of Chemistry
  31. Altered expression of activated induced hepatocellular carcinoma markers (HCCmk) in murine model treated with Portulaca oleracea L.
    Sami Mohamed Nasr, Eman Ahmed El-Wakil, Tarek Aboushousha, Heba Abdel-Hady · 2023 · South African Journal of Botany
  32. Non-receptor Type PTPases and their Role in Controlling Pathways Related to Diabetes and Liver Cancer Signalling
    Nidhee Chaudhary, Bellam Kiranmayee · 2024 · Current Pharmaceutical Biotechnology
  33. Up-Regulation of miR-96-5p Inhibits the Proliferation of FaDu Cell Line by Targeting mTOR
    Weili Liao, Yunzhi Ling, Sui Jiang, Huaxiong Cai · 2017 · Nanoscience and Nanotechnology Letters
  34. Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
    Taoreed Adegoke Azeez, Sharif Adeniyi Folorunso, Chinedu Eguzozie, Adeleke Adedapo Adegboyega · 2021 · Forum of Clinical Oncology
  35. Cancer, Diabetes, and Angiotensin Blockade: A Question of Hypohydration
    Simon Nigel Thornton · 2011 · Journal of Clinical Oncology
  36. Diabetes and Cancer: Evidence for Risk, Methodology and Implications
    Ellena Badrick, Andrew G. Renehan · 2016 · Wiley eBooks
  37. Diabetes and Cancer
    Ellena Badrick, Emily J. Gallagher, Andrew G. Renehan · 2024 · Wiley eBooks
  38. Postprandial Plasma Glucose and Associated Cancer Mortality
    Yutang Wang, Yan Fang, Andreas J. R. Habenicht, Jonathan Golledge, Edward L. Giovannucci, Antonio Ceriello · 2024 · Preprints.org
  39. IGF 1 and IGF 2
    Douglas Yee · 2017 · Springer eBooks
  40. Nutrition
    Kylie O’Brien, Avni Sali · 2017 · Springer eBooks
  41. Changes in physical activity and diabetes risk after cancer diagnosis: a nationwide cohort study
    Wonyoung Jung, In Young Cho, Jin-Hyung Jung, Mi Hee Cho, Hye Yeon Koo, Yong‐Moon Park, Jong-Ha Baek, Kyungdo Han, Dong Wook Shin · 2024 · Journal of Cancer Survivorship
  42. Comorbidities in the Cancer Patient
    Aruna Alahari Dhir, Sandeep Tandon, Sheela Prashant Sawant, Maheema Bhaskar, Anuprita Daddi, Aparna Iyer · 2024 · Springer eBooks
  43. Comparative Study of in vitro Anti-proliferative Activity of Metformin, Teneligliptin, and Canagliflozin against Breast Cancer Cell Line
    Gowri Venugopal, Punnagai Kumaravelu, Sukumar Ramya · 2025 · Journal of Pharmacology and Pharmacotherapeutics
  44. Crosstalk Between the Oncoproteins of High‐Risk Human Papillomaviruses Types 16 and 18 in Colorectal Cancer Cell Models
    Queenie Fernandes, Varghese Philipose Inchakalody, Sarra Mestiri, Takwa Bedhiafi, Shereena Hydrose, Sara S. Bashraheel, Maysaloun Merhi, Said Dermime, Ala‐Eddin Al Moustafa · 2025 · Cancer Reports
  45. The Importance of Understanding the Link Between Diabetes and Cancer
    Chandramohan Kiruthiga, Mamali Das, Arumugam Kamaladevi, Langeswaran Kulanthaivel · 2026 · Springer eBooks
  46. Revisiting the Warburg-Based “Sugar Feeds Cancer” Hypothesis: A Critical Appraisal of Epidemiological, Experimental and Mechanistic Evidence
    Karim Khaled, Hala Jardaly, Byeongsang Oh · 2026 · Onco
  47. Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study
    Furkan Ceylan, Serhat Sekmek, Ateş Kutay Tenekeci, Safa Can Efil, Sena Kaya Ceylan, Efnan Algın, Muhammed Bülent Akıncı, Fahriye Tuğba Köş, Didem Şener Dede, Burak Civelek et al. · 2026 · Future Oncology
  48. The rising burden of obesity-linked cancers in Saudi Arabia: a public health review
    Mohsin Yahya Murshid, Esam Murshid, Nedal Bukhari, Mohammad Alfayez, Tareq Salah, Yasir A. Bahadur · 2026 · Annals of Medicine and Surgery
  49. Association of dual SGLT-2 inhibitor and GLP-1 receptor agonist therapy with colon cancer risk in post-polypectomy patients with diabetes: a target trial emulation
    Chih-Hsuan Wang, Wei-Cheng Chang, Hsin-Yu Chen, Po‐Huang Chen, Ming Hsun Lin, CHO-Hao Lee · 2026 · Diabetology & Metabolic Syndrome
  50. Machine Learning Unveils Dietary Antioxidants as Influential Factors for Diabetes‐Cancer Comorbidity: Insights From National Health and Nutrition Examination Survey
    Ming Xu, Ru Li, Shuqing Jin, Qinhao Liu, Hongxia Wei, Zhe Li, Yuchen Sun, Yi Zhang, YUNFENG LIU · 2026 · Food Science & Nutrition
  51. The impact of comorbid type 2 diabetes on survival outcomes in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis focusing on lung cancer
    Linlin Fan, Weijie Xu, Qiang Zhang, Jin Li, Wenhui Bai · 2026 · Frontiers in Endocrinology
  52. Unravelling the Diabetes-cancer Nexus: An Interlinking Disease with Risk Factors, Screening, Management, Treatments, and Challenges
    Apurva, Priya Chaudhary, Shivani Bahuguna · 2026 · Current Cancer Therapy Reviews
  53. Neue Möglichkeiten der Differenzialtherapie des Typ-2-Diabetes
    M. Schütt, H.H. Klein · 2011 · Der Internist
  54. Staying a Step Ahead of Cancer
    Somaira Nowsheen, Georgiou Alexandros, Eddy S. · 2012 · InTech eBooks
  55. Diabetes and Cancer
    Subhashini Yaturu · 2013 · InTech eBooks
  56. Diabetes, pancreatic cancer and vitamin D. Is there a link?
    Dilnasheen Meerza, Imrana Naseem, Jamal Ahmad · 2011 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  57. Kohortenstudie zur Krebsinzidenz bei Patienten mit Diabetes mellitus Typ 2: Record Linkage von kryptografierten Daten einer externen Kohorte mit Daten des Epidemiologischen Krebsregisters Nordrhein-Westfalen
    Hiltraud Kajüter, Andreas Geier, Ina Wellmann, Volker Krieg, R. Fricke, Oliver Heidinger, Hans‐Werner Hense · 2014 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  58. Promise and prospects of vanadium compounds in medicinal research
    Weixia Bian, Xiao-Gai Yang, Huixue Liu, Yi-Hua Hong, Yi Li · 2016 · Scientia Sinica Chimica
  59. Continuous intraperitoneal insulin infusion (CIPII) for type 1 diabetes: Effective therapy but a case of bad timing?
    Erasmus Mc · 2015
  60. Cytogenetic effects of tick-borne encephalitis in residents of the north of Western Siberia with alimentary-constitutional obesity depending on the polymorphism of the genes of glutathione-S-transferase
    Ekaterina Nikolaevna Ilyinskikh, Nikolay Nikolaevich Ilyinskikh · 2017 · Obesity and metabolism
  61. Metabolic Syndrome and Nutritional Interventions
    Bhawna Kumari, Akanksha Sharma, Umesh C. S. Yadav · 2018 · Springer eBooks
  62. Glucose-Regulated TET2 Activity Links Cancer to Diabetes
    Hari R. Singh, Stefan H. Stricker · 2018 · Trends in cancer
  63. Mathematical Modeling of Type -2 Diabetes Mellitus as a Risk Factor for Cancer
    Deepak Kumar, Richa Gupta, Pooja Khurana · 2021 · Journal of Physics Conference Series
  64. Typ-2 Diabetes
    Morten Schütt · 2015 · Springer eBooks
  65. Human Papilloma Virus-Type 16 (HPV-16) & Human Herpes Virus-Type 8 (HHV-8) infections were found to be co-existing major cancer-contributing factors. Individualized, safe, effective treatment of hopelessly advanced cancer patients with metastasis by combining 4 methods of effective treatment: 1) Optimal dose of Vitamin D3 using its 10 unique beneficial effects, 2) Selective Drug Uptake Enhancement Method, 3) Stimulation of newly discovered Thymus gland representation areas on the back of each hand, & 4) Identification & removal of co-existing cancer-contributing factors
    Yoshiaki Omura, Dominic P. Lu, Harsha Duvvi, Abdallah Nihrane, Yasuhiro Shimotsuura, Motomu Ohki · 2018 · Acupuncture & Electro-Therapeutics Research
  66. An Evidence-Based Review of Diabetes Care: History, Types, Relationship to Cancer and Heart Disease, Co-Morbid Factors, and Preventive Measures
    Umesh Chandra Gupta, Subhas Chandra Gupta, Shayle Sugandh Gupta · 2022 · Current Nutrition & Food Science
  67. Perhexiline Therapy in Patients with Type 2 Diabetes: Incremental Insulin Resistance despite Potentiation of Nitric Oxide Signaling
    Cher‐Rin Chong, Saifei Liu, Hasan Imam, Tamila Heresztyn, Benedetta C. Sallustio, Yuliy Y. Chirkov, John David Horowitz · 2022 · Biomedicines
  68. Study on Common Risk Factors of Retinal Vein Occlusion and Stroke
    超 梁 · 2022 · Hans Journal of Ophthalmology
  69. Correlation between metformin intake and prostate cancer
    Raeun Kim, Minsun Song, Jiwon Shinn, Hun‐Sung Kim · 2023 · Cardiovascular Prevention and Pharmacotherapy
  70. Associations of heart failure to prevalence of haematologic- and solid malignancies in southern Sweden: A cross-sectional study
    Mia Scholten, Anders Halling · 2023 · PLoS ONE
  71. The influence of sociodemographic factors on the control of blood glucose levels among diabetic outpatients visiting various community pharmacies in Lahore
    Muhammad Zahid Iqbal, Naeem Mubarak, Noor Fatima, Laiba Zaheer, Aneeza Safdar, Iqra Mansoor, Neha Fatima, Zonia Iqbal, Amna Razzaq, Tooba Farooq et al. · 2024 · Medical Science
  72. Role of Insulin Use and Social Determinants of Health on Non-melanoma Skin Cancer: Results From the Behavioral Risk Factor Surveillance System
    Nour Massouh, Ayad A. Jaffa, Miran A. Jaffa · 2024 · Cancer Control
  73. Differential Effect of Hyperglycemia on the Odds of Cancer Among the Adult Population of the United States
    P. Ayat, Diana Sawassnajjar, Hussam R Alkaissi, Harjinder Gill, Jennifer Otey, Marwa AlFaraj, Samy I. McFarlane · 2024 · Cureus
  74. Diabetes Mellitus and the Risk of Carcinogenesis: An Interdisciplinary Approach
    Halina Tkaczenko, Piotr Kamiński, Natalia Kurhaluk · 2024 · Interdisciplinary cancer research
  75. Ethnic and Socio-Economic Variations in Comorbidity and Mortality in Cancer Survivors: A UK Population-Based Observational Study
    Tahania A Ahmad, Abu Z M Dayem Ullah, Claude Chelala, Stephanie JC Taylor · 2025 · Cancers
  76. IMDF ‐Net: Iterative U‐Net With Multi‐Kernel Dilated Convolution and Fusion Modules for Enhanced Retinal Vessel Segmentation
    Jiale Deng, Lina Yang, Yu‐Wen Lin · 2025 · International Journal of Imaging Systems and Technology
  77. Unlocking the secrets: Exploring the connection between HPV and bladder cancer in Pakistan
    Hafsa Yousaf, Aneela Javed, Nuzhat Sultana, Khalid Farouk, Muhammad Usman, Gul Rehman Khan, Miriam Kathleen Gomez, Sobia Asghar, Saira Justin · 2025 · Urologic Oncology Seminars and Original Investigations
  78. Diabetes Mellittus and the Risk of Cancer Formation – Possible Link and Review of Literature
    Lawson Ekpeni Ekpe · 2015 · American Journal of Internal Medicine
  79. Cell damage in diabetes mellitus caused by excessive action of insulin
    Макишева, Р Т Макишева · 2016 · Journal of New Medical Technologies
  80. Differential Regulation of IGF-1 and Insulin Signaling by GRKs
    Leonard Girnita, Ada Girnita, Caitrin Crudden · 2016 · Methods in pharmacology and toxicology
  81. Diabetes and Cancers
    Hiroshi Noto · 2017 · Springer eBooks
  82. Diabetes and Cancer: Is there a Link?
    Andra‐Iulia Suceveanu, Adrian‐Paul Suceveanu, Andreea Daniela Gheorghe, Laura Mazilu · 2018 · InTech eBooks
  83. Relationship between type 2 diabetes and pancreatic cancer
    Mehmet Temel Yilmaz, Ali Osman Gürol · 2018 · Translational Medicine Reports
  84. The effect of Metformin on fibrocystic breast disease in women with insulin resistance
    Мусина Екатерина Валентиновна, Igor Yu. Kogan · 2018 · Tumors of female reproductive system
  85. Cancer Risk in Patients with Type 2 Diabetes on Antidiabetic Monotherapy: A Population Based Cohort Study Using National Insurance Health Service Database
    Han Yeong Jung, Sukhyang Lee · 2019 · Korean Journal of Clinical Pharmacy
  86. Leisure-Time Physical Activity Versus Sedentary Behaviour in Relation to Colorectal Adenoma and Cancer: Are these Two Distinct Risk Factors?
    Shahid Mahmood, Robert J. MacInnis, Amalia Karahalios, Dallas R. English, Brigid Mary Lynch · 2020 · Current Colorectal Cancer Reports
  87. Effects of leptin on the viability of MCF-7 and T47D cells at different glucose concentrations.
    Pınar Buket Demırel, Soner Doğan, Ümit Özorhan, Bilge Güvenç Tuna, Todd F. Schuster, Margot P. Cleary · 2020 · PubMed
  88. The Association Between Gender and Complications of Type 2 Diabetes Mellitus Among Patients in Almarj City-Libya
    Fatma KH. Ali Ehmaida, Sokaina Saad Hemdan, Asmaa M. Aljebaly · 2020 · AL-MUKHTAR JOURNAL OF SCIENCES
  89. Cancer Risk in Elderly Korean Patients with Neurodegenerative Disease and its relation to Type 2 Diabetes
    Hee‐Cheol Kim, Ji-Hun Kim, Hojun Lee, Yang‐Tae Kim, Byeong‐Churl Jang · 2023 · The Open Neurology Journal
  90. Evidence for the down-regulation of ATP6V1H gene expression in type 2 diabetes
    Melanie F. Molina · 2017 · Texas ScholarWorks (Texas Digital Library)
  91. Comment on: Yang et al. (2010) Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254–1260
    Riccardo Vigneri, Lidia Sava, Sebastiano Squatrito, Laura Sciacca · 2010 · Diabetes
  92. RE: “ALBUMINURIA, KIDNEY FUNCTION, AND CANCER RISK IN THE COMMUNITY”
    Alexia Bertrand, Ninon Foussard, Marie Monlun, Laurence Blanco, Kamel Mohammedi, Vincent Rigalleau · 2020 · American Journal of Epidemiology
  93. Lower Risks of Incident Colorectal Cancer in SGLT2i Users Compared to DPP4i Users: A Propensity Score-matched Study with Competing Risk Analysis
    Raymond Ngai Chiu Chan, Robert Ngai Fung Chan, Oscar Hou In Chou, Teddy Tai Loy Lee, Leonardo Roever, Guoliang Li, Wing Tak Wong, Abraham Ka Chung Wai, Tong Liu, Gary Tse et al. · 2022 · medRxiv
  94. Association of Diabetes and Cancers: An analysis of the Healthcare Cost and Utilization Project National Inpatient Sample (HCUP-NIS) 2005-2015 Dataset
    Shahryar Zeighami, Ali Seifi, Mohammad Hossein Sharifi, Zahra Gheibi, Alireza Rezvani, Alireza Heiran, Saba Sahraian, Hadis Salimi, Alireza Mirahmadizadeh · 2025 · Research Square
  95. Epidemiology of pancreatic cancer : a global approach
    Cristina Bosetti · 2014 · Research Publications (Maastricht University)
  96. メタボリックシンドロームを合併した日本人2型糖尿病の特徴とその予防(メタボリックシンドロームの治療の進歩,2012年,第53回日本心身医学会総会ならびに学術講演会(鹿児島))
    田尻祐司 · 2013 · 心身医学
  97. Einfluss einer Ernährungsintervention auf das Auftreten von Mikrokernen bei Insulinpflichtigen Typ II Diabetikern
    Marie Therese Katharina Bulla · 2011 · University of Vienna
  98. Evaluation of a novel, serum-based, biomarker screening test for colorectal cancer.
    Hoda Elshoni · 2012 · University Library - University of Saskatchewan (University of Saskatchewan)
  99. Factores genéticos y ambientales relacionados con la génesis de cáncer vesical
    Patricio Navarro Medina · 2013 · Acceda (Universidad de Las Palmas de Gran Canaria)
  100. [Type 2 diabetes mellitus and colorectal cancer: possible molecular mechanisms associated].
    Clara Ibet Juárez-Vázquez, Mónica Alejandra Rosales Reynoso · 2013 · PubMed